Japan’s MHLW Decides Production Method For Bird Flu Vaccines
This article was originally published in PharmAsia News
Executive Summary
The Japanese MHLW has approved a method of producing vaccines in a three-month period, approximately half of the current production period, in case the new strain of bird influenza discovered in China begins spreading from human to human.